Evidence Generation Across the Product Lifecycle: From Pre‑Launch to Post‑Marketing
Evidence needs evolve across the product lifecycle, and successful teams plan proactively to meet those needs at every stage.
Pre‑Launch
Burden‑of‑illness and unmet‑need studies
Early economic models
Treatment landscape assessments
PRO strategy development
Initial RWE feasibility analyses
Launch
Real‑world effectiveness studies
Early utilization and adherence insights
Market access support materials
Payer‑focused evidence communication
Post‑Marketing
Long‑term safety and effectiveness monitoring
Comparative effectiveness research
Subpopulation analyses
Post‑authorization safety studies (PASS)
Ongoing PRO and quality‑of‑life data collection
Why Lifecycle Evidence Matters
Evidence must evolve with the product. Each stage builds on the last, creating a comprehensive picture of clinical, economic, and humanistic value
STEMfluence Perspective: Evidence generation is a continuous journey. Strategic planning ensures that insights remain relevant and impactful.
To Spark Engagement
Map out the evidence needs for a therapy of your choice across three stages: pre‑launch, launch, and post‑marketing.
Identify one evidence gap at each stage and describe how filling that gap could improve patient access or understanding